Primer: IGM Biosciences Inc (IGMS US) - Oct 2025
IGM Biosciences is a clinical-stage biotechnology company centered on a proprietary platform for developing engineered Immunoglobulin M (IgM)...
400 Views
Biopharma Week in Review - January 13, 2025
As investors prepped for company updates and significant news flow, signs of M&A activity were trickling in, with BIIB bidding for SAGE, LLY...
231 Views
Biopharma Week in Review - October 7, 2024
Last week, HIMS and unapproved GLP-1 sellers (LFMD) were put on notice by the FDA. KZR’s study was stopped and placed on clinical hold, but the...
335 Views
No more insights